Angela Riccobon

Summary

Affiliation: Morgagni-Pierantoni Hospital
Country: Italy

Publications

  1. ncbi request reprint Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes
    Angela Riccobon
    Department of Oncology, Pierantoni Hospital AUSL, Forli, Italy
    Cancer Invest 22:871-7. 2004
  2. ncbi request reprint Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Laura Ridolfi
    Istituto Oncologico Romagnola, Pierantoni Hospital, Forli, Italy
    J Immunother 26:156-62. 2003
  3. ncbi request reprint Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma
    Michele Guida
    Oncology Division, Immunology Laboratory, Istituto Oncologico, Bari bImmunotherapy Unit, Oncology Department, Pierantoni Hospital, Forli, Italy
    Melanoma Res 16:317-23. 2006
  4. doi request reprint Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach - single center experience
    Andrea Gardini
    Department of Gastrointestinal and General Surgery, L Pierantoni Hospital, Forli, Italy
    Hepatogastroenterology 59:687-90. 2012
  5. ncbi request reprint Dendritic cell vaccination and immunostimulation in advanced melanoma
    Ruggero Ridolfi
    Dept of Medical Oncology, Pierantoni Hospital, Via Forlanini 34, 47100 Forli, Italy
    Expert Rev Vaccines 2:825-33. 2003
  6. ncbi request reprint Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis
    Andrea Gardini
    Department of Surgery and Transplantation, University of Bologna, Bologna, Italy
    J Surg Oncol 87:46-52. 2004

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes
    Angela Riccobon
    Department of Oncology, Pierantoni Hospital AUSL, Forli, Italy
    Cancer Invest 22:871-7. 2004
    ..10%; p=0.001). The absence or the very low expression of signaling activation molecules in TIL compared with NTTL and PBL in renal cancer patients suggest that tumor-induced immunosuppression generally occurs or starts locally...
  2. ncbi request reprint Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Laura Ridolfi
    Istituto Oncologico Romagnola, Pierantoni Hospital, Forli, Italy
    J Immunother 26:156-62. 2003
    ..Adoptive immunotherapy with TIL and IL-2 could improve DFS and OS, although further work is required to determine its role in the treatment of patients with high-risk melanoma...
  3. ncbi request reprint Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma
    Michele Guida
    Oncology Division, Immunology Laboratory, Istituto Oncologico, Bari bImmunotherapy Unit, Oncology Department, Pierantoni Hospital, Forli, Italy
    Melanoma Res 16:317-23. 2006
    ..In contrast, a progressive increase of interleukin-12 and soluble receptor of interleukin-2 was observed during treatment in patients with a better survival...
  4. doi request reprint Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach - single center experience
    Andrea Gardini
    Department of Gastrointestinal and General Surgery, L Pierantoni Hospital, Forli, Italy
    Hepatogastroenterology 59:687-90. 2012
    ..The literature reports that selected patients may have benefits by pancreatic resection in terms of long term survival. We report patient outcome and considerations on immunotherapy approach...
  5. ncbi request reprint Dendritic cell vaccination and immunostimulation in advanced melanoma
    Ruggero Ridolfi
    Dept of Medical Oncology, Pierantoni Hospital, Via Forlanini 34, 47100 Forli, Italy
    Expert Rev Vaccines 2:825-33. 2003
    ..Many questions remain to be answered before more effective and widespread use of this type of vaccination is possible, especially in the early stages of the disease...
  6. ncbi request reprint Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis
    Andrea Gardini
    Department of Surgery and Transplantation, University of Bologna, Bologna, Italy
    J Surg Oncol 87:46-52. 2004
    ..We assessed the usefulness of immunotherapy with tumor infiltrating lymphocytes (TIL) plus Interleukin-2 (IL-2) as adjuvant treatment...